Bal Pharma Ltd

Board of Directors of the Company has met today and inter alia transacted the following business1. Approved the unaudited financial results ( standalone and consolidated ) for the quarter ended 30.06.2025.2. Convened 38th Annual General meeting of the company on 25th September 2025 at 11.30 am through AV means.3. Decided to close the register of members from 19.09.2025 to 25.09.2025 ( both days inclusive )4. Approved the ESOP -2025 plan subject to the approval of shareholders.5. e-Voting dates from 22.09.2025 to 24.09.2025 for the ensuing Annual General Meeting.